Clinical validation of the CD32b biomarker on the European market

David Marc Weinstock

Polysomy 21 in Acute Lymphoblastic Leukemia

Leukaemia

Hugh-George G Patterton

Reprogramming of the Trypanosoma brucei epigenome during human infection

Non-Hodgkin lymphoma Leukaemia Hodgkin lymphoma

Hematology and hematologic malignancies

Peter D Cole

Markers of Cognitive Decline During Treatment for Childhood ALL

Leukaemia

Helen E. Heslop

SPORE in Lymphoma

Non-Hodgkin lymphoma Leukaemia Hodgkin lymphoma

Hematology and hematologic malignancies

Scott W Lowe

The impact of chromosome 17p lesions on leukemogeneis and therapy response

Leukaemia

Hematology and hematologic malignancies Pathology

Michael L Cleary

Role of PGDH in leukemia pathogenesis

Leukaemia

Kim O'Neill

Cancer Immunology Research at Brigham Young University

Trachea, bronchus and lung Prostate Leukaemia Breast

Peter Stirling

Mechanisms of genome instability induced by RNA splicing defects

Leukaemia

Clark W Distelhorst

Bcl-2 Function on the Endoplasmic Reticulum

Non-Hodgkin lymphoma Multiple myeloma and immunoproliferative diseases Leukaemia

Hematology and hematologic malignancies Pathology